Australia's largest stock trading and investment forum Australia's #1 stock forum

NEURIZON THERAPEUTICS LIMITED

0.00%

15.5¢

Market Cap $76.30M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NEURIZON NUZ-001 OLE CONFIRMS SAFETY SIGNALS

Latest Threads

Tag

Subject

Ann: Notice of Shareholder Update Webinar

31/08/25

23

5.4K

31/08/25

Last post Captain Goodvybes

23

5.4K

NUZ -- New Investor thread

31 32 33

30/08/25

1.9K

647K

30/08/25

Last post Quiltman

1.9K

647K

Pharmaust - Media & News

4 5 6

29/08/25

357

132K

29/08/25

Last post Captain Goodvybes

357

132K

Ann: NUZ-001 Shows Long-Term Safety and Efficacy Signals in OLE

28/08/25

35

6.9K

28/08/25

Last post Van1

35

6.9K

Ann: FDA Review Timeline Extended for NUZ-001 IND Clinical Hold

2

26/08/25

108

20K

26/08/25

Last post Captain Goodvybes

108

20K

Ann: Neurizon to present Q4 updates to Shareholders

26/08/25

1

639

26/08/25

Last post NZ Trader

1

639

Ann: Appendix 4E and 2025 Annual Report

26/08/25

1

576

26/08/25

Last post NZ Trader

1

576

Ann: Appendix 4G and Corporate Governance Statement

26/08/25

0

237

26/08/25

Last post

ASX News

0

237

Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals

21/08/25

2

635

21/08/25

Last post pi065509

2

635

NUZ Charting Thread

2

20/08/25

79

24K

20/08/25

Last post Captain Goodvybes

79

24K

Ann: Neurizon Submits Clinical Hold Complete Response to FDA

2

19/08/25

117

37K

19/08/25

Last post Densy

117

37K

Ann: Neurizon Commences Manufacture of First Registration Batch

13/08/25

11

4.1K

13/08/25

Last post Quiltman

11

4.1K

Ann: Appendix 4C & Quarterly Update

11/08/25

36

10K

11/08/25

Last post Buckland

36

10K

Time to consider a "Covid" revisit?

08/08/25

12

2.8K

08/08/25

Last post Captain Goodvybes

12

2.8K

NUZ TOP HOLDERS AS AT 31 JULY 2025

06/08/25

16

3.9K

06/08/25

Last post balzams

16

3.9K

Ann: AGM Date & Director Nominations Closing Date for AGM

06/08/25

20

5.0K

06/08/25

Last post Bigunks

20

5.0K

See All Discussions

Corporate Spotlight

ABOUT NEURIZON

Timeline

Neurizon to present Q4 updates to Shareholders
26 Aug 10:47	Share

Appendix 4G and Corporate Governance Statement
26 Aug 09:41	Share

Appendix 4E and 2025 Annual Report
26 Aug 09:34	Share

Notice of Shareholder Update Webinar
20 Aug 16:14	Share

NUZ-001 Shows Long-Term Safety and Efficacy Signals in OLE
20 Aug 09:32	Share

FDA Review Timeline Extended for NUZ-001 IND Clinical Hold
15 Aug 09:54	Share

Neurizon Commences Manufacture of First Registration Batch
12 Aug 09:30	Share

AGM Date & Director Nominations Closing Date for AGM
05 Aug 09:03	Share

Appendix 4C & Quarterly Update
30 Jul 09:14	Share

Neurizon Secures Loan Against 2025 R&D Tax Rebate
30 Jul 09:10	Share

Neurizon Submits Clinical Hold Complete Response to FDA
25 Jul 09:22	Share

Positive feedback from FDA on strategy to lift clinical hold
10 Jul 09:15	Share

Presentation Materials - Licensing Agreement Webinar
02 Jul 12:20	Share

Invitation to Shareholder Webinar
02 Jul 08:58	Share

Neurizon Enters Global Licensing Agreement with Elanco
02 Jul 08:49	Share

Notification regarding unquoted securities - NUZ
26 Jun 17:57	Share

Neurizon develops liquid formulation of NUZ-001
26 Jun 09:24	Share

NUZ-001 Shows Significant Blood-Brain Barrier Penetration
20 Jun 09:32	Share

Release of Securities from Escrow
16 Jun 19:12	Share

NUZ-001 Shows Promise in a Model of Huntington's Disease
16 Jun 09:32	Share

Change of Registered Office and Principal Place of Business
02 Jun 09:45	Share

Neurizon to present at Annual ALS Drug Development Summit
14 May 16:54	Share

Neurizon to present Q3 FY2025 Results
06 May 12:48	Share

Last Patient Successfully Completes Treatment in OLE Study
05 May 09:23	Share

Appendix 4C & Quarterly Update
28 Apr 09:11	Share

Notice of Quarterly Shareholder Update Webinar
24 Apr 09:28	Share

Appointment of Chief Financial Officer
22 Apr 09:28	Share

Leadership team strengthened with strategic appointments
17 Apr 09:22	Share

NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells
04 Apr 12:07	Share

NUZ-001 Shows Positive Results in Human 3D Brain Model
01 Apr 09:03	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 15.5¢		Change 0.000(0.00%)		Mkt cap ! $76.30M

Open	High	Low	Value	Volume
16.0¢	16.0¢	15.5¢	$4.206K	26.99K

Buyers (Bids)

No.	Vol.	Price($)
5	396394	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	18939	2

View Market Depth

No.	Vol.	Price($)
5	396394	0.155
9	268886	0.150
2	71500	0.145
1	37427	0.125
3	21624	0.120

Price($)	Vol.	No.
0.160	18939	2
0.165	217213	4
0.170	245507	7
0.175	145000	1
0.180	510883	7

Last trade - 16.10pm 29/08/2025 (20 minute delay)

NUZ (ASX) Chart